Bioequivalence Test for Risperdal 2mg of Janssen Korea
NCT02012049
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Risperdal OD Tab. 2mg
DRUG:
Risperdal Quicklet Tab. 2mg
Sponsor
Janssen Korea, Ltd., Korea